Device / Technology News

RSS

FDA approves absorbable polymer suture that uses DNA technology

The U.S. Food and Drug Administration (FDA) has announced it has cleared for marketing in the U.S. the TephaFLEX Absorbable Suture - the first absorbable polymer suture made from material isolated from bacteria modified by recombinant DNA technology.

12 Feb 2007

New microscopy technology

Research is finding evidence that may solve one of the great puzzles of 21st Century medicine using a new microscopy technology known as CytoViva.

11 Feb 2007

New diagnostic technology for routine prenatal genetic testing

Research studies demonstrating the viability of an approach to routinely detect the presence of fetal DNA in a mother's blood to accurately diagnose or rule out genetic defects -- as early as the first trimester -- was presented today at the 27th Annual Meeting of the Society for Maternal-Fetal Medicine being held in San Francisco.

11 Feb 2007

New hospital gowns to combat MRSA

The fight against the MRSA bug will take a step forward this week when a new-style hospital gown goes on trial at a London hospital.

11 Feb 2007

Smart technology cuts physiotherapy waiting times

Technology with the potential to help cut physiotherapy waiting times has been unveiled by the University of Abertay Dundee.

11 Feb 2007

FDA approves temporary limb salvage shunt

The U.S. Food and Drug Administration (FDA) has cleared for U.S. marketing a vascular shunt, a medical device that can help save the arms and legs of soldiers critically injured in combat as well as individuals in other trauma settings and emergency situations.

11 Feb 2007

Machine learning speeds up Intensity Modulated Radiation Therapy

A new computer-based technique could eliminate hours of manual adjustment associated with a popular cancer treatment.

7 Feb 2007

FDA clears MammaPrint test for marketing

The Food and Drug Administration (FDA) has cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman's initial cancer. It is the first cleared molecular test that profiles genetic activity.

6 Feb 2007

Facial recognition through machine vision is technically possible

The developed approach can be used in automatic and real-time facial expression recognition, and it has many potential computer vision applications.

5 Feb 2007

Direct synthesis of polymer nanocapsules with a noncovalently tailorable surface

To accurately transport pharmaceutical agents to their specific target organs or cell types, you need a good carrier: nanoscopic capsules with surface elements that can "recognize" the target in question could do the trick.

5 Feb 2007

Cancer Research Technology grants Waypharm option to novel platinum agents

Cancer Research Technology Limited (CRT), the cancer-focused development and commercialisation company, today announce that Waypharm S.A.S (Waypharm) has secured rights to evaluate Thioplatin a novel hypoxia-responsive platinum-based cancer therapy, from CRT.

5 Feb 2007

Merck Serono launches growth hormone injection device

Merck Serono has announced the launch of a unique growth hormone injection device, easypod, for the once-daily administration of Saizen (somatropin), the company's recombinant growth hormone deficiency therapy. easypod is the first of its kind in this therapeutic area and was designed to improve patients' ease of daily use, reliability and convenience.

30 Jan 2007

Photoprinted paper supports simultaneous microscale diagnostic tests

Prototype for a new class of inexpensive, highly practical rapid tests that can be used to carry out several biological tests simultaneously on a single drop.

29 Jan 2007

New mobile application for weight control

A Finnish research group with participants from VTT Technical Research Centre of Finland, the University of Tampere and Nokia Research Center has developed a new personal health diary for the mobile phone.

29 Jan 2007

Sequenom and Lenetix to develop Rhesus D prenatal diagnostic

Sequenom, Inc. and Lenetix Medical Screening Laboratory, Inc., a provider of rapid genetic screening and diagnostic testing for clinicians worldwide, today announced that they have entered into a collaboration and license agreement to develop and commercialize a proprietary non-invasive prenatal Rhesus D (RhD) incompatibility test based on Sequenom patent rights and RT PCR methodology.

29 Jan 2007

Smart way of living for people with dementia

A groundbreaking home that uses the latest smart technology to give people with dementia and other serious long-term health conditions greater independence will be showcased for the first time in Bristol.

24 Jan 2007

Are you really what you eat?

Aston University in Birmingham, UK has launched a unique new laboratory facility dedicated to solving the mysteries that lie in the relationship between the food we eat and the human brain.

24 Jan 2007

McGraw-Hil launches AccessEmergency Medicine

McGraw-Hill Professional, a leading global provider of information resources for the scientific and medical communities, today announced the launch of AccessEmergency Medicine

23 Jan 2007

Ultrasensitive optical sensor detects viruses fast

Scientists of the Biophysical Engineering Group of the University of Twente in The Netherlands have developed an ultrasensitive sensor that can be used in a handheld device to, within minutes, detect various viruses and measure their concentration.

22 Jan 2007

Advanced Neuromodulation Systems receives European approval for Rapid Programmer

Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc., has announced European CE Mark approval for its newest clinician programming platform, Rapid Programmer 3.0 for spinal cord stimulation (SCS), an advanced therapy for managing chronic pain.

18 Jan 2007